Yahoo Web Search

  1. Ads
    related to Leukemia
  1. Yahoo Finance Results

  2. BUSINESS WIRE)-- The "Acute Lymphocytic Leukemia Pipeline Highlights - 2017 Update" drug pipelines has been added to Research and Markets' offering. Acute Lymphocytic Leukemia ...

  3. Cancer Space Update: 2 Drugs Receive Regulatory Nod in EU

    Zacks via Yahoo FinanceNov 24 18:59 PM

    On the other hand, Novartis’ NVS Tasigna received approval for label expansion in the first-line setting for paediatric patients with chronic myeloid leukemia. Meanwhile, Johnson & Johnson ...

  4. Hospital today announced that Kutluk Oktay, MD, PhD, the world's leading expert in fertility preservation, performed Long Island's first-ever ovarian transplant at the Hospital, giving new hope ...

  5. Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without the disease worsening than those treated ...

  6. Why Is ImmunoGen (IMGN) Stock Up More Than 150% This Year?

    Zacks via Yahoo FinanceNov 27 23:17 PM

    Shares of ImmunoGen, Inc. IMGN have been massively up 192.7% this year so far, outperforming the industry’s registered 4.3% increase. ImmunoGen’s rapid pipeline progress along with positive ...

  7. BUSINESS WIRE)-- Amphivena Therapeutics Inc. a privately held biotechnology company developing a novel CD33/CD3 T cell engager for the treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic ...

  8. Novartis (NVS) Receives EC Nod for Tasigna Label Expansion

    Zacks via Yahoo FinanceNov 22 13:15 PM

    Novartis AG NVS announced that the European Commission (EC) has approved Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...

  9. As per the latest report by Transparency Market Research (TMR), the global chronic myelogenous leukemia market is expected to witness strong growth. The market is estimated to register ...

  10. Spectrum Doubles in 3 Months: What's Driving the Rally?

    Zacks via Yahoo FinanceNov 27 15:06 PM

    Shares of Spectrum Pharmaceuticals, Inc. SPPI have been rising over the past year. This biotech company has more than doubled in the past three months surging 110%, significantly outperforming the 5.3% rise of the industry in this period.

  1. Ads
    related to Leukemia
  2. See more ads for: